To further improve specificity and cellular uptake, active targeting strategies functionalize nanocarrier surfaces with ligands that bind to receptors overexpressed on cancer cells, such as folic acid for the folate receptor (FR-α) [215] or transferrin for the transferrin receptor (TfR1) [216], promoting receptor-mediated endocytosis. Here, TFRC is linked to cancer.